薬の発見における量子知能:量子機械学習による洞察の進展
Danishuddin1, Azizul Haque1, Vikas Kumar2
1Department of Biotechnology, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Drug discovery today
|September 4, 2025
まとめ
量子機械学習 (QML) は,人工知能 (AI) による薬剤発見の課題に強力な解決策を提供し,分子特性予測と設計の精度とスケーラビリティの向上を約束します.
科学分野:
- 薬学研究
- コンピュータ化学
- 人工知能
背景:
- 機械学習 (ML) の統合は薬物の発見を加速しますが,データと解釈性の課題に直面しています.
- 量子機械学習 (QML) は,製薬アプリケーションにおけるMLの限界を克服するための新しいアプローチとして登場しています.
- QMLは薬の開発における高度なAIのための量子コンピューティングの原理を活用しています
研究 の 目的:
- 医薬品業界における量子機械学習 (QML) の変革的影響について検討する.
- 特性予測と分子設計を含む重要な薬剤発見段階におけるQMLの応用を探求する.
- QMLの現在の限界,倫理的検討,および薬剤発見における将来の見通しについて議論する.
主な方法:
- 薬剤発見における量子機械学習の応用に関する現在の文献のレビュー.
- 分子特性予測とドッキングシミュレーションにおける課題に取り組むためのQMLの可能性の分析.
- 新しい薬の設計と最適化におけるQMLの役割の探求
主要な成果:
- QMLは,分子特性を予測する際の精度とスケーラビリティの改善の可能性を示しています.
- 量子強化ドッキングシミュレーションにより 薬剤候補の特定が より迅速で精度が高いことが示されています
- QMLは効率を高める革新的な de novo分子設計を可能にします.
結論:
- QMLは 薬学研究における 伝統的なMLよりも 重要な進歩です
- QMLのコンピューティングとデータ要件に対処することは,その広範な採用に不可欠です.
- 将来の研究は,堅牢なQMLアルゴリズムを開発し,薬剤発見の倫理的な意味を探求することに重点を置くべきです.
さらに関連する動画
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.1K
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.9K
関連する概念動画
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Quantitative Aspects of Drug-Receptor Interaction
1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
The Quantum-Mechanical Model of an Atom
43.4K
Shortly after de Broglie published his ideas that the electron in a hydrogen atom could be better thought of as being a circular standing wave instead of a particle moving in quantized circular orbits, Erwin Schrödinger extended de Broglie’s work by deriving what is now known as the Schrödinger equation. When Schrödinger applied his equation to hydrogen-like atoms, he was able to reproduce Bohr’s expression for the energy and, thus, the Rydberg formula governing hydrogen spectra.
43.4K
